NIH Data Commons Pilot Phase OT3

The purpose of the announcement is to invite applications from applicants who have an interest in performing high impact, cutting-edge scientific and computing activities necessary to establish an NIH Data Commons. The goal of the NIH Data Commons is to accelerate new biomedical discoveries by providing a cloud-based platform where investigators can store, share, access, and compute on digital objects (data, software, etc.) generated from biomedical research and perform novel scientific research including hypothesis generation, discovery, and validation. Applicants are encouraged to develop innovative approaches to one or more key computational, data, analytical and scientific capabilities of the Data Commons. These key capabilities are described in detail in the announcement.

Awards under Research Opportunity Announcement RM-17-026 will made using Other Transactions (OTs), which are not grants, cooperative agreements, or contracts. It is essential applicants carefully follow the instructions in the announcement as they likely will be different from what they are used to seeing.


Letters of Intent (LOIs) are required, and are due June 30, 2017 (5:00 PM United States Eastern Time).  LOIs will be used to select individuals or groups who will be invited to submit an application by July 12. Only those who are invited may apply. Applications submitted without an invitation from the NIH will be returned and not reviewed. NIH expects to make several OT awards under this announcement. The planned budget for this announcement is $21 million over a 4-year period.


Inquiries about RM-17-026 should be directed to:

FOA Link:

Administrative Supplements to NIBIB Grants: Technologies to Catalyze New Discoveries in Alzheimer's Disease and Related Dementias

The National Institute of Biomedical Imaging and Bioengineering (NIBIB), in partnership with the National Institute on Aging (NIA), announces an opportunity for NIBIB-supported investigators to request administrative supplements to develop new tools, technologies and approaches for the prevention, diagnosis, treatment and understanding of Alzheimer's Disease and Alzheimer's-disease-related dementias (AD/ADRD). These supplements will be funded by NIA as part of the NIA strategic plan to support the development of innovative strategies to prevent, diagnose and treat AD/ADRD.

Administrative supplement requests should be submitted to PA-16-287, Administrative Supplements to Existing NIH Grants and Cooperative Agreements The requested supplemental budget cannot exceed $100,000 in direct costs for up to 12 months. The project and budget periods of the supplement request must be within the currently approved project period for the existing parent award.

Supplements will be considered for active NIBIB-funded projects that may have important application in AD/ADRD. Administrative supplements may be awarded to meet increased costs that are within the scope of the approved award, but were unforeseen when the application was submitted. For the purposes of this Notice, "within scope" may include the addition of an AD/ADRD-relevant component to a project employing or developing a broadly applicable technology. Applicants are strongly encouraged to discuss the aims of the proposed work with the NIBIB program officer assigned to the parent grant to assess suitability for this funding opportunity.

Requests must be received by July 3, 2017. 

Funding Opportunities

Application Due Date:
Monday, May 1, 2017, Tuesday, August 1, 2017, Wednesday, November 1, 2017, Thursday, February 1, 2018, Tuesday, May 1, 2018, Wednesday, August 1, 2018, Thursday, November 1, 2018
Application Due Date:
Monday, September 25, 2017
Application Due Date:
Monday, January 30, 2017, Monday, May 29, 2017, Friday, September 29, 2017


Webinar Date
Tuesday, May 30, 2017 - 12:00pm to Thursday, December 31, 2020 - 12:30pm

MSM Meetings

The MultiBioMe 2017 is the inaugural edition of a new, biennial series of scientific gatherings, offering a

Meeting Date:
Monday, September 11, 2017 to Wednesday, September 13, 2017
Meeting Location:
Vienna, Austria

Understanding brain function requires characterizing the interactions occurring across many temporal and spatial scales. Mechanistic multiscale modeling aims to organize and explore these interactions across these scales. Multiscale models can provide insights into how changes at the molecular and cellular levels affect dynamics at local networks and brain areas. At the highest levels, they allow us to connect neural activity to theories of behavior, memory and cognition.

Meeting Date:
Tuesday, September 12, 2017 to Wednesday, September 13, 2017
Meeting Location:
Göttingen, Germany

Physical Concepts and Computational Models in Immunology: a discussion forum for studies across scales of space and time
SCALES: Cellular, Organismic, Population

PDF iconPCCMI Symposium Poster.pdf

Meeting Date:
Wednesday, October 11, 2017 to Thursday, October 12, 2017

This wiki contains information relevant to the IMAG (Interagency Modeling and Analysis Group) and the MSM (Multi-scale Modeling Consortium)Questions about IMAG and the MSM Consortium can be directed to